Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: A systematic review

ASN Neuro

Volumn 6, Issue 3, 2014, Pages 185-192

  Cordeiro, Joana L C ^a   Marques Jr , Wilson ^a   Hallak, Jaime E C ^b   Osório, Flávia L ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Nacional de Medicina Translacional   (Brazil)

Author keywords

Charcot Marie Tooth; Comorbidity; Hereditary motor sensory neuropathy; Mental disorder; Psychiatry; Quality of life

Indexed keywords

ANXIETY; ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; PREVALENCE; QUALITY OF LIFE; RATING SCALE; SLEEP; STRUCTURED INTERVIEW; SYSTEMATIC REVIEW; COMPLICATION; MENTAL DISEASE; PSYCHOLOGY;

CHARCOT-MARIE-TOOTH DISEASE; HUMANS; MENTAL DISORDERS; QUALITY OF LIFE;

EID: 84901719538     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20130048     Document Type: Article

References (41)

1. Arnold A., Entagardt M, Younger DS (2005) Psychosocial issues that face patients with Charcot-Marie-Tooth disease: the role of genetic counselling. J Genet Couns 14:307-318.
2. Boentert M., Dziewas R, Heidbreder A, Happe S, Kleffner I, Young P (2010) Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J Neurol 257:646-652.
3. Boentert M., Knop K, Schuhmacher C, Gess B, Okegwo A, Young P (2014) Sleep disorders in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 85:319-325.
4. Calvert M., Pall H, Hoppitt T, Eaton B, Savil E, Sackley C (2012) Health-related quality of life and supportive care in patients with rare long-term neurological conditions. Qual Life Res 22:1231-1238.
5. Carson A. J, Postma K, Stone J, Warlow C, Sharpe M (2003) The outcome of depressive disorders in neurology patients: a prospective cohort study. J Neurol Neurosurg Psychiatry 74:893-896.
6. Del-ben CM, Vilela JAA, Crippa JAS, Hallak JEC, Labate CM, Zuardi AW (2001) Test-retest reliability of the Structured Clinical Interview for DSM-IV-Clinical Version (SCID-CV) translated into Portuguese. Rev Bras Psiquiatr 23:156-159.
7. Dematteis M., Pépin JL, Jeanmart M, Deschaux C, Labarre-Vila A, Lévy P (2001) Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study. Lancet 357:267-272.
8. Dziewas R., Waldmann N, Boentert H, Hor T, Muller A, Okegwo E, Ringelstein P, Young P (2008) Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study. J Neurol Neurosurg Psychiatry 79:829-831.
9. Gemignani F., Marbini A, Giovanni D, Salih S, Terzano MG (1999) Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology 52:1064.
10. Genari A. B, Borghetti VHS, Gouvêa SP, Bueno KC, dos Santos PL, dos Santos AC, Barreira AA, Lourenço CM, Marques Jr W (2011) Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2. Neuromusc Disord 21:428-432.
11. Hattan E., Colin Chalk C, Postuma RB (2009) Is there a higher risk of restless legs syndrome in peripheral neuropathy? Neurology 72:955.
12. Higgins J. PT, Green S (2011), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration.
13. Kalkman J. S, Schillings ML, Zwarts MJ, Van Engelen BGM, Bleijenberg G (2007) Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I. Acta Neurol Scand 115:265-270.
14. Lobentanz I. S, Asenbaum S, Vass K (2004) Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 110:6-13.
15. Mayo N. E, Wood-dauphinee S, Cote R, Durcan L, Carlton J (2002) Activity, participation, and quality of life 6 months poststroke. Arch Phys Med Rehabil 83:1035-42.
16. Marques W. J, Freitas MR, Oliveira ASB, Calia L, Melo A, Lucena R, Rocha V, Barreira A. A (2005) 17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population. J Neurol 252:972-979.
17. Marques W. J, Hanna MG, Marques S (1999) Phenotypic variation of a new P) mutation in genetically identical twins. J Neurol 246:596-599.
18. Moher D., Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097.
19. Murphy S. M, Laura M, Fawcet K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke J. M, Castleman V, Manji H, Lunn MP, Bull K, Ramdharry G, Davis M, Blake J. C, Houlden H, Reilly MM (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706-710.
20. Padua L., Aprile I, Cavallaro T, Commodari I, La Torre G, Pareyson D, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A; Italian CMT QoL Study Group (2006) Variables influencing quality of life and disability in Charcot-Marie-Tooth (CMT) patients: Italian multicentre study. Neurol Sci 27:417-423.
21. Padua L., Aprile I, Cavallaro T, Commodari I, Quattrone A, Rizzuto N, Vita G, Schenone A. (2008a) Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study. Neurol Sci 29:157-162.
22. Padua L., Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, Vita G, Tonali P., Schenone A (2008b) Natural history of CMT1A including Qol: a 2-year prospective study. Neuromuscul Disord 18:199-203.
23. Padua L., Shy Me, Aprile I, Cavallaro T, Pareyson D, Quattrone A, Rizzuto N, Vita G., Tonali P, Schenone A (2008c) Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst 13:64-70.
24. Patzko A., Shy ME (2012) Charcot-Marie-Tooth disease and related genetic neuropathies. Continuum Lifelong Learning Neurol 18:39-59.
25. Pfeiffer G., Wicklein EM, Ratusinski T, Schmitt L, Kunze K (2001) Disability and quality of life in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 70:548-50.
26. Phillips M. F, Steer HM, Soldan JR, Wiles CM, Harper PS (2009) Daytime somnolence in myotonic dystrophy. J Neurol 246:275-82.
27. Redmond A. C, Burns J, Ouvrier RA (2008) Factors that influence health-related quality of life in Australian adults with Charcot-Marie-Tooth disease. Neuromuscul Disord 18:619-25.
28. Rubinsztein J. S, Rubinsztein DC, Goodburn S, Holland AJ (1998) Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 64:510-5.
29. Rutkove S. B, Matheson JK, Logigian EL (1995) Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 63:670-672.
30. Saporta A. SD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME (2011) Charcot-Marie-Tooth: disease subtypes and genetic testing strategies. Ann Neurol 69:22-33.
31. Schrag A. (2004) Psychiatric aspects of Parkinson's disease, an update. J Neurol 51:795-804.
32. Shy M. E, Rose MR (2005) Charcot-Marie-Tooth disease impairs quality of life: Why? And how do we improve it?. Neurology 65:790-791.
33. Skre H. (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 6:98-118.
34. Stavem K., Lossius MI, Kvien TK, Guldvog B (2000) The health-related quality of life of patients with epilepsy compared with angina pectoris, rheumatoid arthritis, asthma and chronic obstructive pulmonary disease. Qual Life Res 9:865-871.
35. Surtees P. G, Wainwright NWJ, Khaw KT, Day NE (2003) Functional health status, chronic medical conditions and disorders of mood. Br J Psychiatry 183:299-303.
36. Tapp R. J, Dunstan DW, Phillips P, Tonkin A, Zimmet PZ, Shaw JE (2006) Association between impaired glucose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study. Diabetes Res Clin Pract 74:154-161.
37. Teunissen L. L, Notermans NC, Franssen H, Van Engelen BG, Baas F, Wokke JH (2003) Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study. Arch Neurol 60:823-828.
38. Thomas P. K, Marques W Jr, Davis M, Sweeney MG, King RH, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120:465-478.
39. Van der Werf S, Van Der Broek H, Anten H, Bleijenberg G (2001) Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur J Neurol 45:28-33.
40. Vinci P., Gargiulo P, Panunzi M, Baldini L (2009) Psychological distress in patients with Charcot-Marie-Tooth disease. Eur J Phys Rehabil Med 45:385-389.
41. Vinci P., Serrao M, MIllul A, Deidda A, De Santis F, Capici S, Martini D, Pierelli F, Santilli V (2005) Quality of life in patients with Charcot-Marie-Tooth disease. Neurology 27:922-924.